Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research

Frontiers in Medicine - Switzerland
doi 10.3389/fmed.2017.00071
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Frontiers Media SA

Related search

Food and Drug Administration, Center for Drug Evaluation and Research

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2007English

Anti-Infective Agents, Biologics, and Vaccines Approved by the U.S. Food and Drug Administration's Center for Drug Evaluation and Research in 1993.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Regulatory Policy for Research and Development of Vaccines for Public Health Emergencies

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Medical Research and Public Health.

Nature
Multidisciplinary
1912English

Php343 - Clinical Development of Biologics Approved by the U.S. Food and Drug Administration, 2003-2016

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

From Laboratory Research to the Public: Science Communication for Policy, Research Community and Public

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pesticide Regulatory Activities of the Food and Drug Administration

American Journal of Public Health and the Nations Health
1965English

Advancing Research in NeuroAIDS Using Collaboration and Public Data Sharing

BMC Medical Genomics
Genetics
2015English

Conducting Research at the Interface of Food Science and Nutrition

Journal of Food Science
Food Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy